FDA Approves Adaptive DBS for Parkinson’s Patients

Image caption: Future technology will also address other Parkinson’s symptoms, like depression and sleep dysfunction. Image credit: Neuroscience News. Article by Robin Marks. Neuroscience News – February 25, 2025. Source: UCSF. 

Summary: The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms. Unlike traditional DBS, which delivers constant stimulation, aDBS monitors brain activity and responds with precise electric pulses to prevent stiffness and involuntary movements. Two approved algorithms target […]

Click here to view original web page at neurosciencenews.com